This chapter presents the Noordwijk Medicines Agenda (NMA), which puts forward a set of concrete actions and policy options to promote, in a coherent manner, an open innovation strategy that can deliver new generations of drugs, vaccines and diagnostics
for neglected infectious diseases. The chapter highlights what the OECD can bring to this issue and sets out the following areas for action: policy coherence; basic research; new models and policy mechanisms; more open innovation; collaborative mechanisms;
global virtual collaborative drug development network; other areas requiring innovation, including regulatory approaches and new technologies and processes; building capacity in disease endemic countries; financing mechanisms; and delivery systems. The message
from the NMA is that no one can do this alone; there needs to be more partnerships, networks and policy coherence to achieve the common goals of developing an innovation system that can deal with today's challenges. This is an opportunity for governments to drive a health
innovation strategy that is more efficient and responsive to global public health needs.